Even if the basis for cyclin E prognostic significance is not known, a major hypothesis is that cyclin E overexpression reflects alterations in any part of the p16–cyclinD–Rb–E2F pathway, which is mutated in most cancers. This evidence concerns the gene RB1 and cancer.